The Russian Ministry of Health registered the vaccine against birch pollen allergy «Allergarda» before completion of Phase III clinical trials. In the results of Phases I–II published in September, researchers described five cases of grade 3 anaphylaxis; all patients received treatment and recovered without consequences.

#Allergard #Generium #MinzdravRossii #Nanolek #birchpollen #FMBA

Read more

At the end of September, Russian medical institutions will receive the first batch of «Cegardex» — the first domestically produced vaccine against human papillomavirus (HPV). By the end of the year, up to 600,000 doses are planned to be produced.

#HPV #KirovOblast #Nanolek #CompulsoryMedicalInsurance #IndustrialDevelopmentFund #Cegardex

Read more